Synthetic Bone Graft Substitutes - Medical Devices Pipeline Assessment, 2017

  • ID: 4401993
  • Report
  • 221 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Advanced Biologics LLC
  • Baxter International Inc
  • Citrics Biomedical, LLC
  • King's College London
  • NuVasive Inc
  • RepRegen Ltd.
  • MORE
Synthetic Bone Graft Substitutes - Medical Devices Pipeline Assessment, 2017

Summary

The Medical Devices sector report, “Synthetic Bone Graft Substitutes - Medical Devices Pipeline Assessment, 2017" provides an overview of Synthetic Bone Graft Substitutes currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Synthetic Bone Graft Substitutes pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Synthetic Bone Graft Substitutes under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Synthetic Bone Graft Substitutes and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry
Reasons to buy
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Synthetic Bone Graft Substitutes under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Advanced Biologics LLC
  • Baxter International Inc
  • Citrics Biomedical, LLC
  • King's College London
  • NuVasive Inc
  • RepRegen Ltd.
  • MORE
1 Table of Contents
2 Introduction
2.1 Synthetic Bone Graft Substitutes Overview
3 Products under Development
3.1 Synthetic Bone Graft Substitutes - Pipeline Products by Stage of Development
3.2 Synthetic Bone Graft Substitutes - Pipeline Products by Territory
3.3 Synthetic Bone Graft Substitutes - Pipeline Products by Regulatory Path
3.4 Synthetic Bone Graft Substitutes - Pipeline Products by Estimated Approval Date
3.5 Synthetic Bone Graft Substitutes - Ongoing Clinical Trials
4 Synthetic Bone Graft Substitutes - Pipeline Products under Development by Companies
4.1 Synthetic Bone Graft Substitutes Companies - Pipeline Products by Stage of Development
4.2 Synthetic Bone Graft Substitutes - Pipeline Products by Stage of Development
5 Synthetic Bone Graft Substitutes Companies and Product Overview
5.1 Advanced Biologics LLC Company Overview
5.2 Aeon Astron Corporation Company Overview
5.3 Agenta Biotechnologies Inc Company Overview
5.4 Allegra Orthopaedics Ltd Company Overview
5.5 Alphatec Holdings Inc Company Overview
5.6 Amend Surgical, Inc. Company Overview
5.7 Anika Therapeutics Inc Company Overview
5.8 Baxter International Inc Company Overview
5.9 Berkeley Advanced Biomaterials Inc Company Overview
5.10 Bio2 Technologies, Inc. Company Overview
5.11 Bone Solutions Inc Company Overview
5.12 BoneGrafix, Inc. Company Overview
5.13 BoneSupport AB Company Overview
5.14 Calcitec, Inc. Company Overview
5.15 Citrics Biomedical, LLC (Inactive) Company Overview
5.16 curasan AG Company Overview
5.17 DSM Biomedical BV Company Overview
5.18 Graftys SA Company Overview
5.19 Inion Oy Company Overview
5.20 Innovia LLC Company Overview
5.21 King's College London Company Overview
5.22 Kuros Biosciences AG Company Overview
5.23 Maxigen Biotech Inc Company Overview
5.24 Meta Biomed Co Ltd Company Overview
5.25 N2 Biomedical Company Overview
5.26 National Center of Innovation for Biomaterials in Orthopaedic Research Company Overview
5.27 NovaBone Products LLC Company Overview
5.28 NuVasive Inc Company Overview
5.29 Orthocell Ltd Company Overview
5.30 Orthogem Company Overview
5.31 Orthogen LLC Company Overview
5.32 PolyPid Ltd Company Overview
5.33 Promimic AB Company Overview
5.34 RepRegen Ltd. (Inactive) Company Overview
5.35 Revivicor Inc Company Overview
5.36 San Raffaele hospital Company Overview
5.37 Scil Technology GmbH Company Overview
5.38 SIRAKOSS Ltd Company Overview
5.39 Sofregen Medical Inc Company Overview
5.40 Soft Tissue Regeneration Inc Company Overview
5.41 Soteira Inc Company Overview
5.42 Trinity College Dublin Company Overview
5.43 University of California San Diego Company Overview
5.44 University of Edinburgh Company Overview
5.45 University of Nottingham's School Of Pharmacy Company Overview
5.46 Wound Management Technologies Inc Company Overview
5.47 Wright Medical Group NV Company Overview
6 Synthetic Bone Graft Substitutes- Recent Developments
6.1 Aug 29, 2017: Globus Medical Appoints David M. Demski as CEO
6.2 Aug 29, 2017: NuVasive Announces World-Class Innovation Center At San Diego Headquarters
6.3 Aug 28, 2017: Kuros receives clearance for MagnetOs Putty for commercialization in the United States and files the product for CE marking in Europe
6.4 Aug 28, 2017: Anika Announces Appointment of Steven Chartier as Vice President of Regulatory and Clinical Affairs
6.5 Aug 25, 2017: Sr-­HT-­Gahnite Bone Substitute Project Update
6.6 Aug 22, 2017: Medtronic Reports First Quarter Financial Results
6.7 Aug 17, 2017: BONESUPPORT Holding: Interim Report January - June 2017
6.8 Aug 15, 2017: NuVasive Appoints Rajesh J. Asarpota As Chief Financial Officer
6.9 Aug 14, 2017: Governor McAuliffe Announces LifeNet Health to Invest $12.25 million, Create 321 New Jobs in City of Virginia Beach
6.10 Aug 14, 2017: aap: Q2 sales and EBITDA in line with guidance; 14% sales growth in trauma in H1/2017aap: Q2 sales and EBITDA in line with guidance; 14% sales growth in trauma in H1/2017Berlin, 14 August 2017
6.11 Aug 10, 2017: Alphatec Holdings Reports Second Quarter 2017 Financial Results
6.12 Aug 09, 2017: Novadaq Receives Court Approval for Arrangement With Stryker
6.13 Aug 08, 2017: RTI Surgical Announces 2017 Second Quarter Results
6.14 Aug 02, 2017: Globus Medical Reports Second Quarter 2017 Results
6.15 Aug 02, 2017: Wright Medical Group Reports 2017 Second Quarter Financial Results
6.16 Aug 02, 2017: Stryker announces election of new Director, Mary K. Brainerd
6.17 Jul 27, 2017: Hoya Reports First Quarter Financial Results
6.18 Jul 27, 2017: Zimmer Biomet Reports Second Quarter 2017 Financial Results
6.19 Jul 27, 2017: Stryker reports second quarter 2017 results
6.20 Jul 27, 2017: Anika Announces Appointment of Joseph Darling as President
6.21 Jul 27, 2017: NuVasive Announces New Organizational Structure To Drive Growth And Profitability Goals
6.22 Jul 27, 2017: NuVasive Reports Second Quarter 2017 Financial Results
6.23 Jul 26, 2017: Baxter Reports Second-Quarter 2017 Results and Provides Updated Financial Outlook for 2017 and 2020
6.24 Jul 26, 2017: Integra LifeSciences Reports Second Quarter 2017 Financial Results
6.25 Jul 26, 2017: Anika Reports Strong Second Quarter 2017 Financial Results
6.26 Jul 20, 2017: Wound Management Technologies Announces Q2 2017 Sales Up 15% over Q2 2016 and All Amortized Debt Retired in the Second Quarter
6.27 Jul 18, 2017: Spineway: Confirmed growth Revenue for the first half of 2017: €6M (+146%)
6.28 Jul 17, 2017: Baxter Appoints Cathy R. Smith to its Board
6.29 Jul 11, 2017: Zimmer Biomet Announces Leadership Transition
6.30 Jul 11, 2017: Zimmer Biomet Reports Certain Preliminary Second Quarter 2017 Results
6.31 Jul 11, 2017: Medicrea Reports First Half 2017 Sales
6.32 Jun 15, 2017: aap: Supervisory Board extends both Management Board members’ contracts prematurely until the end of 2020
6.33 Jun 14, 2017: Spineway Records a New $1M Order in the USA
6.34 Jun 13, 2017: Zimmer Biomet Holdings Announces Resolution of FDA Warning Letter Related to Its Zhejiang, China Manufacturing Facility
6.35 Jun 06, 2017: Kuros Biosciences submits MagnetOs Putty for US FDA Clearance
6.36 Jun 01, 2017: NuVasive Appoints Skip Kiil As Executive Vice President, International
6.37 May 31, 2017: Depuy Synthes and Ethicon to Showcase Intra Operative Solutions Aiming to Mitigate Surgical Site Infection During Efort Congress
6.38 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results
6.39 May 24, 2017: NovaBone Announces Irrigation Resistant Products with Carriers that have Synergistic Effect in Bone Formation
6.40 May 24, 2017: NovaBone Provides Update on NovaBone IRM MacroPO
6.41 May 22, 2017: BONESUPPORT Announces First Patient Enrolled in FORTIFY Trial With CERAMENT G, a Novel Injectable, Antibiotic-eluting Bone Graft Substitute
6.42 May 22, 2017: NuVasive Announces Educational Initiatives In Support Of Spine's Fastest Growing Spinal Deformity Portfolio
6.43 May 17, 2017: Wound Management Issues 2017 10Q and Hires New Strategic Marketing Director
6.44 May 11, 2017: Hoya Reports Fourth Quarter and Full-Year Financial Results
6.45 May 11, 2017: Alphatec Reports First Quarter 2017 Financial Results
6.46 May 03, 2017: Globus Medical Reports First Quarter 2017 Results
6.47 May 03, 2017: Wright Medical Group Reports 2017 First Quarter Financial Results
6.48 May 03, 2017: Anika Reports First Quarter 2017 Financial Results
6.49 Apr 28, 2017: Lennart Johansson to Join BONESUPPORT Board of Directors
6.50 Apr 27, 2017: Zimmer Biomet Reports First Quarter 2017 Financial Results
6.51 Apr 27, 2017: RTI Surgical Announces 2017 First Quarter Results
6.52 Apr 27, 2017: Q1 2017 Sales Up 32% Over Q1 2016, for Wound Management Technologies
6.53 Apr 26, 2017: Integra LifeSciences Reports First Quarter 2017 Financial Results
6.54 Apr 26, 2017: Baxter Reports First-Quarter 2017 Results and Increases Financial Outlook for Full-Year 2017
6.55 Apr 26, 2017: Spineway: 2016 Annual results
6.56 Apr 25, 2017: Stryker reports first quarter 2017 results
6.57 Apr 25, 2017: NuVasive Announces First Quarter 2017 Financial Results
6.58 Apr 13, 2017: Medicrea Releases First Quarter Sales For 2017
6.59 Apr 11, 2017: BONESUPPORT Appoints Michael Diefenbeck as Chief Medical Officer
6.60 Mar 31, 2017: aap: Annual financial statements for 2016: aap with fundamental progress in strategy implementation - Transformation to a pure player in trauma completed
6.61 Mar 30, 2017: Medicrea Announces 2016 Annual Results
6.62 Mar 24, 2017: Alphatec Completes its Senior Leadership Team with Appointment of Brian Snider, Executive Vice President, Strategic Marketing and Product Development
6.63 Mar 15, 2017: Alphatec Holdings Announces Fourth Quarter and Full Year 2016 Financial Results
6.64 Mar 09, 2017: PolyPid Announces Positive Interim Data from Company's Confirmatory Clinical Trial for BonyPid-1000 Antibiotic Eluting Bone Substitute
6.65 Mar 08, 2017: Wound Management announces appointment of John Siedhoff as Chairman
6.66 Feb 28, 2017: Synergy Biomedical Receives CE Mark for BIOSPHERE PUTTY
6.67 Feb 27, 2017: Globus Medical Reports Full Year and Fourth Quarter 2016 Results
6.68 Feb 23, 2017: RTI Surgical Announces 2016 Fourth Quarter, Full Year Results; Initiates Actions to Improve Execution and Return to Profitable Growth
6.69 Feb 23, 2017: Integra LifeSciences Reports Fourth Quarter and Full-Year 2016 Financial Results and Updates 2017 Full-Year Guidance
6.70 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results
6.71 Feb 21, 2017: Wright Medical Group Reports 2016 Fourth Quarter and Full-Year Financial Results and Provides 2017 Guidance
6.72 Feb 15, 2017: Anika Reports Fourth Quarter and Full Year 2016 Financial Results
6.73 Feb 15, 2017: Anika Therapeutics Reports 33% Revenue Growth in Third Quarter 2011
6.74 Feb 14, 2017: Alphatec Spine Announces Appointment of David H. Mowry to its Board of Directors
6.75 Feb 14, 2017: Wound Management Technologies Announces Record Quarterly and Annual Sales Ending December 31, 2016 - Up 147% over Q4 2015, and 63% over 2015
6.76 Feb 10, 2017: Allegra Orthopaedics Provides Update on Sr-HT-Gahnite Bone Substitute Project
6.77 Feb 09, 2017: NuVasive Reports Fourth Quarter And Full Year 2016 Financial Results
6.78 Feb 08, 2017: Baxter Appoints Dr. Stephen Oesterle to Its Board
6.79 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors
6.80 Feb 01, 2017: Baxter Reports 2016 Fourth-Quarter and Full-Year Results
6.81 Jan 31, 2017: Zimmer Biomet Reports Fourth Quarter and Full-Year 2016 Financial Results
6.82 Jan 31, 2017: Hoya Announces Third Quarter Financial Results
6.83 Jan 26, 2017: RTI Surgical Names Camille Farhat Chief Executive Officer
6.84 Jan 26, 2017: Calmare Theraeutics Board of Directors Changes
6.85 Jan 24, 2017: Stryker reports 2016 results and 2017 outlook
6.86 Jan 18, 2017: Karolinska Development portfolio company Promimic appoints Magnus Larsson as new CEO and launches US sales operation
6.87 Jan 17, 2017: Zimmer Biomet Announces Americas Leadership Transition
6.88 Jan 17, 2017: RTI Surgical Extends Deadline for Nominating Directors to the Board
6.89 Jan 16, 2017: SurgaColl Technologies: Board Announcement - Appointment of CEO
6.90 Jan 12, 2017: Zimmer Biomet Announces Resolution with DOJ and SEC Regarding Previously Disclosed Legacy Biomet FCPA Matters
6.91 Jan 12, 2017: Medicrea Releases Annual Sales for 2016
6.92 Jan 10, 2017: Stryker provides 2016 preliminary net sales results
6.93 Jan 10, 2017: Zimmer Biomet Announces Fourth Quarter and Full-Year 2016 Preliminary Sales Results
6.94 Jan 10, 2017: Globus Medical Reports Preliminary Fourth Quarter and Full Year Sales Results
6.95 Jan 09, 2017: NuVasive Announces Select Preliminary Unaudited Full Year 2016 Financial Results and 2017 Outlook
6.96 Jan 06, 2017: BONESUPPORT CEO Richard Davies to present at Medtech Showcase 2017
6.97 Jan 03, 2017: Calmare Therapeutics Reports Third Quarter 2016 Results
6.98 Dec 21, 2016: Bjorn Westberg to Join BONESUPPORT as Chief Financial Officer
6.99 Dec 16, 2016: BONESUPPORT Confirms Election of Dr. Hakan Bjorklund as Chairman of the Board
6.100 Dec 14, 2016: RTI Surgical Names Robert P. Jordheim Interim CEO
6.101 Dec 14, 2016: Zimmer Biomet Update on Product Supply Matters and Responsive Statement on Recently Completed FDA Inspection
6.102 Dec 12, 2016: Alphatec Holdings appoints new CEO
6.103 Dec 12, 2016: Alphatec Holdings Announces Board and Executive Leadership Changes
6.104 Dec 08, 2016: Wound Management Technologies Welcomes J. Michael Carmena as its New CFO
6.105 Dec 07, 2016: curasan receives market clearance for orthopedic product in the strategically important US market
6.106 Dec 05, 2016: Integra LifeSciences announces management changes
6.107 Dec 05, 2016: Integra LifeSciences Announces Key Executive Appointments
6.108 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results
6.109 Nov 22, 2016: Collagen Matrix Names Oystein Valberg as Chief Financial Officer
6.110 Nov 17, 2016: New UK Business Manager Appointed At JRI Orthopaedics
6.111 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report
6.112 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction
6.113 Nov 10, 2016: Curasan Continues Dynamic Growth in the Third Quarter
6.114 Nov 09, 2016: Alphatec Holdings Announces Third Quarter 2016 Revenue and Financial Results
6.115 Nov 08, 2016: Globus Medical Reports Third Quarter 2016 Results
6.116 Nov 07, 2016: BONESUPPORT Announces Key Corporate Appointment To Drive Growth In North America
6.117 Nov 03, 2016: DSM Q3 2016 Results
6.118 Nov 02, 2016: Wright Medical Group Reports 2016 Third Quarter Financial Results and Updates 2016 Guidance
6.119 Nov 01, 2016: Wound Management Technologies Reports Preliminary Financial Results For Q3 2016 Sales Up 56% over Q3 2015, and 2016 YTD Sales Up 41% over 2015 YTD Sales
6.120 Oct 31, 2016: Allegra Orthopaedics Provides Update on Sr-HT-Gahnite Bone Substitute
6.121 Oct 31, 2016: Zimmer Biomet Reports Third Quarter 2016 Financial Results
6.122 Oct 28, 2016: Hoya Reports Second Quarter Results
6.123 Oct 27, 2016: Karolinska Development Portfolio Company Promimic Appoints New Chairman and Directors to its Board
6.124 Oct 27, 2016: Stryker reports third quarter 2016 results
6.125 Oct 27, 2016: Integra LifeSciences Reports Third Quarter 2016 Financial Results
6.126 Oct 26, 2016: Anika Reports Third Quarter 2016 Financial Results
6.127 Oct 25, 2016: RTI Surgical Announces 2016 Third Quarter Results
6.128 Oct 25, 2016: Baxter Reports Third Quarter 2016 Results and Increases Financial Outlook For Full-Year 2016
6.129 Oct 25, 2016: NuVasive Reports Third Quarter 2016 Financial Results
6.130 Oct 06, 2016: Medicrea Announces 2016 Third-Quarter Sales
6.131 Oct 05, 2016: Alphatec Holdings Announces Company Updates
6.132 Sep 27, 2016: Orange County Business Council Study Showcases Economic Impact of Allergan on California Economy
7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Synthetic Bone Graft Substitutes - Pipeline Products by Stage of Development
Table 2: Synthetic Bone Graft Substitutes - Pipeline Products by Territory
Table 3: Synthetic Bone Graft Substitutes - Pipeline Products by Regulatory Path
Table 4: Synthetic Bone Graft Substitutes - Pipeline Products by Estimated Approval Date
Table 5: Synthetic Bone Graft Substitutes - Ongoing Clinical Trials
Table 6: Synthetic Bone Graft Substitutes Companies - Pipeline Products by Stage of Development
Table 7: Synthetic Bone Graft Substitutes - Pipeline Products by Stage of Development
Table 8: Advanced Biologics LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 9: OsteoMEM Synthetic Bone Graft Substitute - Product Status
Table 10: OsteoMEM Synthetic Bone Graft Substitute - Product Description
Table 11: Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 12: BioBone Filler - Product Status
Table 13: BioBone Filler - Product Description
Table 14: Agenta Biotechnologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 15: B-247 Cranial Bone Graft Implant - Product Status
Table 16: B-247 Cranial Bone Graft Implant - Product Description
Table 17: Allegra Orthopaedics Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Sr-HT-Gahnite Bone Substitute - Product Status
Table 19: Sr-HT-Gahnite Bone Substitute - Product Description
Table 20: Alphatec Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Bonex - Product Status
Table 22: Bonex - Product Description
Table 23: Amend Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Biomimetic Bone - Product Status
Table 25: Biomimetic Bone - Product Description
Table 26: Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Hyalobone - Product Status
Table 28: Hyalobone - Product Description
Table 29: Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Synthetic Bone Graft - Orthopaedic - Product Status
Table 31: Synthetic Bone Graft - Orthopaedic - Product Description
Table 32: Synthetic Bone Graft - Spinal - Product Status
Table 33: Synthetic Bone Graft - Spinal - Product Description
Table 34: Berkeley Advanced Biomaterials Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 35: CPA Ceramics - Product Status
Table 36: CPA Ceramics - Product Description
Table 37: HAP Ceramics - Product Status
Table 38: HAP Ceramics - Product Description
Table 39: Bio2 Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Hammertoe Intramedullary Fusion Device - Product Status
Table 41: Hammertoe Intramedullary Fusion Device - Product Description
Table 42: Bone Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 43: Osteocrete - Bone Anchor - Product Status
Table 44: Osteocrete - Bone Anchor - Product Description
Table 45: OsteoCrete - Cranial - Product Status
Table 46: OsteoCrete - Cranial - Product Description
Table 47: OsteoCrete - Maxillofacial - Product Status
Table 48: OsteoCrete - Maxillofacial - Product Description
Table 49: OsteoCrete - Non Load Bearing Spine - Product Status
Table 50: OsteoCrete - Non Load Bearing Spine - Product Description
Table 51: BoneGrafix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 52: Solid Bone Block - Product Status
Table 53: Solid Bone Block - Product Description
Table 54: BoneSupport AB Pipeline Products & Ongoing Clinical Trials Overview
Table 55: Cerament - G - Product Status
Table 56: Cerament - G - Product Description
Table 57: BoneSupport AB - Ongoing Clinical Trials Overview
Table 58: Cerament - G - A Prospective, Randomized Multicenter Controlled Trial of CERAMENT - G as Part of Surgical Repair of Open Diaphyseal Tibial Fractures
Table 59: Cerament - G - CERAMENT lBONE VOID FILLER and Gentamicin Eluting CERAMENT lG for Prophylactic Use in Bone Tumor Patients
Table 60: Cerament - G - CERAMENT/G - Bone Healing and Re-infection Prophylaxis
Table 61: Calcitec, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 62: Corticell - Product Status
Table 63: Corticell - Product Description
Table 64: Citrics Biomedical, LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 65: CitrOSponge - Product Status
Table 66: CitrOSponge - Product Description
Table 67: curasan AG Pipeline Products & Ongoing Clinical Trials Overview
Table 68: Cerasorb Classic Ortho - Product Status
Table 69: Cerasorb Classic Ortho - Product Description
Table 70: Cerasorb M Ortho - Product Status
Table 71: Cerasorb M Ortho - Product Description
Table 72: Cerasorb Ortho Foam - Product Status
Table 73: Cerasorb Ortho Foam - Product Description
Table 74: Cerasorb Paste - Product Status
Table 75: Cerasorb Paste - Product Description
Table 76: DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview
Table 77: Structural Synthetic Bone Graft - Product Status
Table 78: Structural Synthetic Bone Graft - Product Description
Table 79: Graftys SA Pipeline Products & Ongoing Clinical Trials Overview
Table 80: GRFT-M04 - Product Status
Table 81: GRFT-M04 - Product Description
Table 82: GRFT-R02 - Product Status
Table 83: GRFT-R02 - Product Description
Table 84: Injectable Resorbable Material - Product Status
Table 85: Injectable Resorbable Material - Product Description
Table 86: Intelligent Bone Substitute - Infection - Product Status
Table 87: Intelligent Bone Substitute - Infection - Product Description
Table 88: Intelligent Bone Substitute - Post-Operative Intraosseous Pain - Product Status
Table 89: Intelligent Bone Substitute - Post-Operative Intraosseous Pain - Product Description
Table 90: Inion Oy Pipeline Products & Ongoing Clinical Trials Overview
Table 91: Biodegradable Cervical Interbody Fusion Block - Product Status
Table 92: Biodegradable Cervical Interbody Fusion Block - Product Description
Table 93: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 94: Vertebral Disc Filler - Product Status
Table 95: Vertebral Disc Filler - Product Description
Table 96: King's College London Pipeline Products & Ongoing Clinical Trials Overview
Table 97: Bone Graft Substitute - Product Status
Table 98: Bone Graft Substitute - Product Description
Table 99: Kuros Biosciences AG Pipeline Products & Ongoing Clinical Trials Overview
Table 100: MagnetOs Putty - Orthopedic And Dental - Product Status
Table 101: MagnetOs Putty - Orthopedic And Dental - Product Description
Table 102: MagnetOs Putty - Spinal Fusion - Product Status
Table 103: MagnetOs Putty - Spinal Fusion - Product Description
Table 104: Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 105: Formasetin Injectable Bone Filler - Product Status
Table 106: Formasetin Injectable Bone Filler - Product Description
Table 107: MaxiCure - Product Status
Table 108: MaxiCure - Product Description
Table 109: MaxiSetin - Product Status
Table 110: MaxiSetin - Product Description
Table 111: Meta Biomed Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 112: Bone Filler - Product Status
Table 113: Bone Filler - Product Description
Table 114: N2 Biomedical Pipeline Products & Ongoing Clinical Trials Overview
Table 115: Antimicrobial Biodegradable Bone Graft - Product Status
Table 116: Antimicrobial Biodegradable Bone Graft - Product Description
Table 117: National Center of Innovation for Biomaterials in Orthopaedic Research Pipeline Products & Ongoing Clinical Trials Overview
Table 118: Composite Bone Graft Substitute - Product Status
Table 119: Composite Bone Graft Substitute - Product Description
Table 120: NovaBone Products LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 121: Bioengineered Resorbable Bone Graft - Orthopedic - Product Status
Table 122: Bioengineered Resorbable Bone Graft - Orthopedic - Product Description
Table 123: NuVasive Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 124: AttraX Putty - Product Status
Table 125: AttraX Putty - Product Description
Table 126: NuVasive Inc - Ongoing Clinical Trials Overview
Table 127: AttraX Putty - A Randomized Controlled Trial of AttraX Putty vs. Autograft in Instrumented Posterolateral Spinal Fusion
Table 128: Orthocell Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 129: CelGro Collagen Scaffold - Bone Void Filling - Product Status
Table 130: CelGro Collagen Scaffold - Bone Void Filling - Product Description
Table 131: Orthogem Pipeline Products & Ongoing Clinical Trials Overview
Table 132: TriPore Putty - Product Status
Table 133: TriPore Putty - Product Description
Table 134: Orthogen LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 135: DentoGen-CR - Product Status
Table 136: DentoGen-CR - Product Description
Table 137: PolyPid Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 138: BonyPid-1000 - Product Status
Table 139: BonyPid-1000 - Product Description
Table 140: PolyPid Ltd - Ongoing Clinical Trials Overview
Table 141: BonyPid-1000 - Safety and Performance of BonyPid-1000 in the Treatment of Gustilo IIIA and IIIB Tibial Open Fractures
Table 142: Promimic AB Pipeline Products & Ongoing Clinical Trials Overview
Table 143: HAnano Bone - Product Status
Table 144: HAnano Bone - Product Description
Table 145: RepRegen Ltd. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 146: Bone Graft Substitute - Load Bearing - Product Status
Table 147: Bone Graft Substitute - Load Bearing - Product Description
Table 148: StronBone-P - Product Status
Table 149: StronBone-P - Product Description
Table 150: Revivicor Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 151: Tendon - ACL Repair - Product Status
Table 152: Tendon - ACL Repair - Product Description
Table 153: San Raffaele hospital Pipeline Products & Ongoing Clinical Trials Overview
Table 154: Tissue Repair Composite Scaffold - Product Status
Table 155: Tissue Repair Composite Scaffold - Product Description
Table 156: Scil Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 157: ST01 Bone Graft Substitute Material - Product Status
Table 158: ST01 Bone Graft Substitute Material - Product Description
Table 159: SIRAKOSS Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 160: MaxSi Graft Granules - Product Status
Table 161: MaxSi Graft Granules - Product Description
Table 162: MaxSi Graft Putty - Product Status
Table 163: MaxSi Graft Putty - Product Description
Table 164: Sofregen Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 165: SeriACL Scaffold - Product Status
Table 166: SeriACL Scaffold - Product Description
Table 167: SeriCuff Scaffold - Product Status
Table 168: SeriCuff Scaffold - Product Description
Table 169: Soft Tissue Regeneration Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 170: L-C Ligament - Product Status
Table 171: L-C Ligament - Product Description
Table 172: Soteira Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 173: Nanotechnology Bone Biomaterial - Spinal Repair - Product Status
Table 174: Nanotechnology Bone Biomaterial - Spinal Repair - Product Description
Table 175: Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview
Table 176: Drug Eluting Porous Scaffold - Product Status
Table 177: Drug Eluting Porous Scaffold - Product Description
Table 178: University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview
Table 179: Synthetic Bone Graft - Product Status
Table 180: Synthetic Bone Graft - Product Description
Table 181: University of Edinburgh Pipeline Products & Ongoing Clinical Trials Overview
Table 182: Shapeable Foam - Bone Repair - Product Status
Table 183: Shapeable Foam - Bone Repair - Product Description
Table 184: University of Nottingham's School Of Pharmacy Pipeline Products & Ongoing Clinical Trials Overview
Table 185: Injectable Bone - Product Status
Table 186: Injectable Bone - Product Description
Table 187: Wound Management Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 188: Bone Void Filler - Product Status
Table 189: Bone Void Filler - Product Description
Table 190: Wright Medical Group NV Pipeline Products & Ongoing Clinical Trials Overview
Table 191: Augment Chronic Tendinopathy - Product Status
Table 192: Augment Chronic Tendinopathy - Product Description
Table 193: Augment Injectable Bone Graft - Product Status
Table 194: Augment Injectable Bone Graft - Product Description
Table 195: Augment Rotator Cuff Graft - Product Status
Table 196: Augment Rotator Cuff Graft - Product Description
Table 197: Glossary

List of Figures
Figure 1: Synthetic Bone Graft Substitutes - Pipeline Products by Stage of Development
Figure 2: Synthetic Bone Graft Substitutes - Pipeline Products by Territory
Figure 3: Synthetic Bone Graft Substitutes - Pipeline Products by Regulatory Path
Figure 4: Synthetic Bone Graft Substitutes - Pipeline Products by Estimated Approval Date
Figure 5: Synthetic Bone Graft Substitutes - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Advanced Biologics LLC
  • Aeon Astron Corporation
  • Agenta Biotechnologies Inc
  • Allegra Orthopaedics Ltd
  • Alphatec Holdings Inc
  • Amend Surgical, Inc.
  • Anika Therapeutics Inc
  • Baxter International Inc
  • Berkeley Advanced Biomaterials Inc
  • Bio2 Technologies, Inc.
  • Bone Solutions Inc
  • BoneGrafix, Inc.
  • BoneSupport AB
  • Calcitec, Inc.
  • Citrics Biomedical, LLC
  • curasan AG
  • DSM Biomedical BV
  • Graftys SA
  • Inion Oy
  • Innovia LLC
  • King's College London
  • Kuros Biosciences AG
  • Maxigen Biotech Inc
  • Meta Biomed Co Ltd
  • N2 Biomedical
  • National Center of Innovation for Biomaterials in Orthopaedic Research
  • NovaBone Products LLC
  • NuVasive Inc
  • Orthocell Ltd
  • Orthogem
  • Orthogen LLC
  • PolyPid Ltd
  • Promimic AB
  • RepRegen Ltd.
  • Revivicor Inc
  • San Raffaele hospital
  • Scil Technology GmbH
  • SIRAKOSS Ltd
  • Sofregen Medical Inc
  • Soft Tissue Regeneration Inc
  • Soteira Inc
  • Trinity College Dublin
  • University of California San Diego
  • University of Edinburgh
  • University of Nottingham's School Of Pharmacy
  • Wound Management Technologies Inc
  • Wright Medical Group NV
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll